<p>Lumexa Imaging（納斯達克代碼：LMRI - 獲取免費報告）在週一的研究報告中被 Raymond James Financial 的股票研究員從 “跑贏大盤” 評級上調至 “強力買入” 評級，MarketBeat 報道。該券商目前對該股票的目標價為 23.00 美元。Raymond James Financial 的目標價意味着該公司當前價格有 112.96% 的潛在上漲空間。</p>
<p>獲取 <strong>Lumexa Imaging</strong> 的提醒：</p>
<h2>Lumexa Imaging 股票上漲 6.5%</h2>
<p>週一 LMRI 開盤價為 10.80 美元。Lumexa Imaging 的 12 個月低點為 9.97 美元，12 個月高點為 19.45 美元。</p>
<h2>Lumexa Imaging 的機構交易</h2>
<p>一家機構投資者最近在 Lumexa Imaging 股票中建立了新頭寸。根據該公司在最近向證券交易委員會的披露，Assetmark Inc.在第四季度收購了 Lumexa Imaging Holdings, Inc.（納斯達克代碼：LMRI - 免費報告）的新頭寸。該基金收購了 1,957 股公司股票，價值約 36,000 美元。</p>
<h2>關於 Lumexa Imaging</h2>
<p>（獲取免費報告）</p>
<p>我們是美國最大的診斷影像服務提供商之一 (1)。我們的平台是集成的、可擴展的，並且在為我們的利益相關者創造價值方面有着良好的業績記錄。截至 2025 年 9 月 30 日，我們及其附屬公司在美國運營着第二大 (1) 門診影像中心網絡，覆蓋 13 個州的 184 箇中心 (2)，並與醫療系統建立了八個合資夥伴關係。我們的中心位於具有吸引力的大都市統計區（“MSAs”）。</p>
<h2>另見</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Lumexa Imaging</li>
<li>你的銀行賬户不再安全</li>
<li>黃金市場崩潰的那一天</li>
<li>一位前 CIA 特工對即將到來的崩潰的看法</li>
<li>他剛剛準確預測了另一個黃金走勢……</li>
<li>~$1.5T SpaceX IPO：首次公開募股機會</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Lumexa Imaging 嗎？</h2>
<p>在考慮 Lumexa Imaging 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户在更廣泛的市場注意到之前立即購買的股票……而 Lumexa Imaging 並不在名單上。</p>
<p>儘管 Lumexa Imaging 目前在分析師中獲得了強力買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

LMRI

<p>Raymond James Financial 將 Lumexa Imaging (NASDAQ:LMRI) 的評級從 “跑贏大盤” 上調至 “強力買入”，目標價為 23.00 美元，意味着相較於當前價格有 112.96% 的潛在上漲空間。該股票開盤價為 10.80 美元，反映出 6.5% 的漲幅。Lumexa Imaging 在 13 個州運營着 184 家門診影像中心，是美國最大的診斷影像服務提供商之一</p>

<p>Lumexa Imaging (NASDAQ:LMRI - Get Free Report) was upgraded by equities researchers at Raymond James Financial from an &#34;outperform&#34; rating to a &#34;strong-buy&#34; rating in a research note issued to investors on Monday, MarketBeat reports. The brokerage presently has a $23.00 price objective on the stock. Raymond James Financial's target price points to a potential upside of 112.96% from the company's current price.</p>
<div class="lb-trans"><p>Lumexa Imaging（納斯達克代碼：LMRI - 獲取免費報告）在週一的研究報告中被 Raymond James Financial 的股票研究員從 “跑贏大盤” 評級上調至 “強力買入” 評級，MarketBeat 報道。該券商目前對該股票的目標價為 23.00 美元。Raymond James Financial 的目標價意味着該公司當前價格有 112.96% 的潛在上漲空間。</p>
</div><p>Get <strong>Lumexa Imaging</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Lumexa Imaging</strong> 的提醒：</p>
</div><h2>Lumexa Imaging Stock Up 6.5%</h2>
<div class="lb-trans"><h2>Lumexa Imaging 股票上漲 6.5%</h2>
</div><p>LMRI opened at $10.80 on Monday. Lumexa Imaging has a twelve month low of $9.97 and a twelve month high of $19.45.</p>
<div class="lb-trans"><p>週一 LMRI 開盤價為 10.80 美元。Lumexa Imaging 的 12 個月低點為 9.97 美元，12 個月高點為 19.45 美元。</p>
</div><h2>Institutional Trading of Lumexa Imaging</h2>
<div class="lb-trans"><h2>Lumexa Imaging 的機構交易</h2>
</div><p>An institutional investor recently bought a new position in Lumexa Imaging stock. Assetmark Inc. acquired a new position in Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,957 shares of the company's stock, valued at approximately $36,000.</p>
<div class="lb-trans"><p>一家機構投資者最近在 Lumexa Imaging 股票中建立了新頭寸。根據該公司在最近向證券交易委員會的披露，Assetmark Inc.在第四季度收購了 Lumexa Imaging Holdings, Inc.（納斯達克代碼：LMRI - 免費報告）的新頭寸。該基金收購了 1,957 股公司股票，價值約 36,000 美元。</p>
</div><h2>About Lumexa Imaging</h2>
<div class="lb-trans"><h2>關於 Lumexa Imaging</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2) across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).</p>
<div class="lb-trans"><p>我們是美國最大的診斷影像服務提供商之一 (1)。我們的平台是集成的、可擴展的，並且在為我們的利益相關者創造價值方面有着良好的業績記錄。截至 2025 年 9 月 30 日，我們及其附屬公司在美國運營着第二大 (1) 門診影像中心網絡，覆蓋 13 個州的 184 箇中心 (2)，並與醫療系統建立了八個合資夥伴關係。我們的中心位於具有吸引力的大都市統計區（“MSAs”）。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Lumexa Imaging</li>
<li>Your Bank Account Is No Longer Safe</li>
<li>The day the gold market broke</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
<li>He just nailed another gold prediction …</li>
<li>~$1.5T SpaceX IPO: Pre-IPO Opportunity</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Lumexa Imaging</li>
<li>你的銀行賬户不再安全</li>
<li>黃金市場崩潰的那一天</li>
<li>一位前 CIA 特工對即將到來的崩潰的看法</li>
<li>他剛剛準確預測了另一個黃金走勢……</li>
<li>~$1.5T SpaceX IPO：首次公開募股機會</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Lumexa Imaging Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Lumexa Imaging 嗎？</h2>
</div><p>Before you consider Lumexa Imaging, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Lumexa Imaging 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lumexa Imaging wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户在更廣泛的市場注意到之前立即購買的股票……而 Lumexa Imaging 並不在名單上。</p>
</div><p>While Lumexa Imaging currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>儘管 Lumexa Imaging 目前在分析師中獲得了強力買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Lumexa Imaging（納斯達克代碼：LMRI）在 Raymond James Financial 被提升至 “強力買入” 評級